SVB Wealth LLC Makes New Investment in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

SVB Wealth LLC purchased a new position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 6,218 shares of the company’s stock, valued at approximately $267,000. SVB Wealth LLC owned approximately 0.13% of SPDR S&P Pharmaceuticals ETF at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its stake in SPDR S&P Pharmaceuticals ETF by 36.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,443 shares of the company’s stock worth $197,000 after purchasing an additional 1,182 shares in the last quarter. Sigma Planning Corp purchased a new position in SPDR S&P Pharmaceuticals ETF in the 4th quarter worth about $221,000. AlphaMark Advisors LLC increased its stake in SPDR S&P Pharmaceuticals ETF by 6.7% in the 4th quarter. AlphaMark Advisors LLC now owns 6,640 shares of the company’s stock worth $285,000 after purchasing an additional 415 shares in the last quarter. Arlington Financial Advisors LLC purchased a new position in SPDR S&P Pharmaceuticals ETF in the 4th quarter worth about $291,000. Finally, Stifel Financial Corp purchased a new position in SPDR S&P Pharmaceuticals ETF in the 3rd quarter worth about $337,000.

SPDR S&P Pharmaceuticals ETF Price Performance

NYSEARCA:XPH opened at $44.19 on Thursday. SPDR S&P Pharmaceuticals ETF has a fifty-two week low of $38.88 and a fifty-two week high of $48.76. The stock’s 50-day moving average is $44.25 and its two-hundred day moving average is $44.79. The stock has a market cap of $161.29 million, a PE ratio of 15.75 and a beta of 0.73.

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.